EirGenix, Inc.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.eirgenix.com
Clinical Trials
6
Active:2
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 3
4 (66.7%)Phase 1
2 (33.3%)Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Patients With HER2-positive Hormone Receptor Negative Early Breast Cancer.
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- EirGenix, Inc.
- Target Recruit Count
- 380
- Registration Number
- NCT06884254
- Locations
- 🇺🇸
Methodist Health System Clinical Research Institute, Dallas, Texas, United States
A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Breast Cancer
- Interventions
- Drug: 420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection
- First Posted Date
- 2022-07-25
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- EirGenix, Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT05471648
- Locations
- 🇩🇪
CRS Clinical Research Services Berlin GmbH, Berlin, Germany
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- EirGenix, Inc.
- Target Recruit Count
- 807
- Registration Number
- NCT03433313
- Locations
- 🇺🇸
Detroit Clinical Research Center, Farmington Hills, Michigan, United States
🇺🇸Aultman Hospital, Cancer Center, Canton, Ohio, United States
🇧🇾Brest Regional Oncology Center, Brest, Belarus
A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2017-06-08
- Lead Sponsor
- EirGenix, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT03180242
News
No news found